Company patents
Merative US L.P.
Merative US L.P. exhibits a surprising and significant shift in its patent strategy, moving away from its core focus on Healthcare Informatics, which represents 79.1% of its portfolio but saw an 83.3% decline in patent grants in 2025. This decline is mirrored across almost all categories, including Machine Learning & AI (-88.9% in 2025) and Natural Language Processing (-100% in 2025), suggesting a broad de-emphasis on new patent filings across its technology domains, with only 1 patent granted in 2025 for Machine Learning & AI and 0 for several other categories.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
67 US filings (since 2023) · 12 categories · 15 themes
Utilizing machine learning, particularly deep learning, to analyze medical data such as images, sensor readings, or physiological signals for disease prediction, diagnosis, or treatment assessment.
Computational methods and systems for analyzing biological data (e.g., genomic, proteomic, clinical) to diagnose diseases, predict patient prognosis, assess treatment response, or stratify patients for therapy.
Application of machine learning models to process complex data and generate actionable insights, predictions, or classifications that inform or automate decision-making processes in various domains like healthcare, business, or industrial control.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Digital platforms and systems that deliver tailored therapeutic interventions, guidance, or recommendations to patients based on their individual health data, biometric feedback, and computational models (e.g., AI/ML, physiological simulations).
Systems that process data to provide personalized recommendations, predict events, or automate decision-making processes based on learned patterns, user behavior, or environmental factors.
Systems and methods utilizing artificial intelligence, particularly large language models and neural networks, to extract, summarize, generate, or categorize information from unstructured or semi-structured data sources.
Methods and systems for identifying, extracting, and structuring specific entities, relationships, or insights from text-based documents, often involving techniques like named entity recognition, relation extraction, or summarization.
Systems and methods for automating the lifecycle of machine learning models, including pipeline deployment, model management, versioning, and configuring for different inference environments.
Techniques utilizing deep learning models like Generative Adversarial Networks (GANs) or diffusion models to create new images, modify existing ones, or generate synthetic data based on various inputs or conditions.
Algorithms and hardware optimizations for rapidly identifying and characterizing relevant visual features (e.g., objects, motion, gradients) from images or video streams, often integrating machine learning for feature representation and recognition, with a focus on real-time performance and reduced computational cost.
Applying computational methods, often involving machine learning and multiomics data, to design, analyze, and understand biomolecules, genetic sequences, or complex biological systems.
Methods and systems for combining and analyzing diverse biological datasets (e.g., genomics, transcriptomics, proteomics, metabolomics) to uncover complex biological relationships, disease mechanisms, or temporal trajectories.
Patents
Showing 1-10 of 70